or Try an Advanced Search...

    Selective Estrogen Receptor Degraders Stocks List

    Symbol Grade Name % Change
    GTHX A G1 Therapeutics, Inc. 0.00
    ZNTL D Zentalis Pharmaceuticals, Inc. 21.61
    OLMA F Olema Pharmaceuticals, Inc. 0.78
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antiestrogens Biopharmaceutical Breast Cancer Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Treatment Of Breast Cancer Cancer Drugs Epidermal Growth Factor Receptor Fulvestrant Receptor Positive Clinical Medicine Medicine Metastatic Breast Cancer Molecule Therapeutics Protein Kinase Inhibitor Targeted Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Selective Estrogen Receptor Degraders stocks.

    Symbol Grade Name Weight
    ARB A AltShares Merger Arbitrage ETF 1.72
    CNCR F Loncar Cancer Immunotherapy ETF 1.22
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 1.0
    EVNT B AltShares Event-Driven ETF 0.77
    SBIO B ALPS Medical Breakthroughs ETF 0.61
    View all Selective Estrogen Receptor Degraders ETFs...
    Compare ETFs
    Compare ARB to CNCR Compare CNCR to BBC Compare EVNT to SBIO

        Selective Estrogen Receptor Degraders Stocks Recent News

        Date Stock Title
        Oct 31 OLMA Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation
        Related Industries: Biotechnology
        Related Stock Lists: Antiestrogens Biopharmaceutical Breast Cancer Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Treatment Of Breast Cancer Cancer Drugs Epidermal Growth Factor Receptor Fulvestrant Receptor Positive Clinical Medicine Medicine Metastatic Breast Cancer Molecule Therapeutics Protein Kinase Inhibitor Targeted Therapy
        Selective Estrogen Receptor Degraders

        Selective Estrogen Receptor Degraders (SERDs) are a class of drugs that target the estrogen receptor and reduce its activity. They are used to treat hormone-dependent breast cancer and other estrogen-related conditions. SERDs work by blocking the binding of estrogen to its receptor, thus reducing the amount of estrogen that can activate the receptor. This can help reduce the growth of cancer cells that rely on estrogen for growth and survival.

        Browse All Tags